Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARROW trial of OM-85 for recurrent preschool wheeze
ACTRN12620001370998Phase 3Active, not recruiting
- Sponsor
- Deakin University
- Start
- Apr 2022
- Modality
- Whole Cell Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in recurrent wheeze and wheeze comparing Broncho-Vaxom with Placebo (2 arms). Primary endpoint: Hospital admission due to acute wheezing illness. Started Apr 2022; status: active, not recruiting.
02
Drugs
OM-85
03
Conditions
recurrent wheezewheeze
Beyond the preview
Go deeper on ACTRN12620001370998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620001370998.